The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Open accessAbstract
Fungal infections are a major contributor to infectious disease-related deaths across the globe. Candida species are among the most common causes of invasive mycotic disease, with Candida albicans reigning as the leading cause of invasive candidiasis. Given that fungi are eukaryotes like their human host, the number of unique molecular targets that can be exploited for antifungal development remains limited. Currently, there are only three major classes of drugs approved for the treatment of invasive mycoses, and the efficacy of these agents is compromised by the development of drug resistance in pathogen populations. Notably, the emergence of additional drug-resistant species, such as Candida auris and Candida glabrata, further threatens the limited armamentarium of antifungals available to treat these serious infections. Here, we describe our current arsenal of antifungals and elaborate on the resistance mechanisms Candida species possess that render them recalcitrant to therapeutic intervention. Finally, we highlight some of the most promising therapeutic strategies that may help combat antifungal resistance, including combination therapy, targeting fungal-virulence traits, and modulating host immunity. Overall, a thorough understanding of the mechanistic principles governing antifungal drug resistance is fundamental for the development of novel therapeutics to combat current and emerging fungal threats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, large-scale genomic alterations, including aneuploidy, loss-of-heterozygosity (LOH), and chromosomal rearrangements, can affect the expression of drug targets, efflux pumps, and other resistance factors (7).”
From Potential role of lysine acetylation in the stepwise adaptation of Candida albicans to fluconazole (2025) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“These mutations lead to either the overexpression of the enzyme itself (14) or alterations in its activity that can lower fluconazole’s binding strength, leading to reduced drug effectiveness (15).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [15]
In the citing paper
“the only new class of antifungal drugs developed in decades, the echinocandins, displays negligible antifungal activity against Cryptococcus spp.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“Treatment options for invasive cryptococcal infection are limited, given that Cryptococcus spp. are intrinsically resistant to echinocandins and that they employ an arsenal of defences that enable resistance to azoles2,8.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“the polyene amphotericin B has been the primary treatment for cryptococcal infection for more than half a century, despite the fact that it causes substantial toxicity and that its availability is limited by economic and logistical constraints2,4”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“current antifungal drug treatments for invasive fungal infections are limited to polyenes, azoles and echinocandins2”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“Combination therapy has the potential to confer enhanced efficacy and fungal selectivity while reducing vulnerability to the evolution of resistance2.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,455
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555
Flagged first, then by citations
Research works printed but not linked: 1
- Besterman, J.; Nguyen, D. T.; Ste-Croix, H. MGCD290, an Oral Fungal Hos2 Inhibitor, Enhances the Antifungal Properties of Fluconazole Following Multiple-or Single-Dose Oral Administration in Pre-and Post-Infection Settings. In Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) ; MethylGene, Inc.: San Francisco, CA, 2012; Vol. Poster M-1711.
Cited by
Sorted by citations
Items 601–700 of 823
Advances in tuberculosis co-infections: Mechanisms, diagnosis, and therapeutics
He, S., Luan, C., Gao, J., Lu, F., Tian, F., Muh, F., Zhang, S., Chen, Y., & He, X. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108131 · Cited by 1
Shan, J., Gao, Y., Su, J., Xu, R., Zhang, C., Fu, Y., & Wang, G. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-06282-4 · Cited by 1
Current scenario of antifungal resistance and the drugs in the pipeline
Sengar, D., Burade, D. K., Chaudhari, B. P., & Gajbhiye, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29273-6.00014-x · Cited by 1
Gao, Y., Su, J., Yuan, J., Cao, Q., Wu, Y., Xiao, Y., Yang, G., Xia, R., Yang, J., Li, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202518196 · Cited by 1
Jin, W., Xu, Y., Xu, Z., Song, J., Zhou, X., Liu, C., Wang, L., Wang, Z., Weng, J., & Chen, Y. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-025-12496-9 · Cited by 1
Кандидоз у новорожденных: новые решения старой проблемы (обзор литературы)
Альбертовна, С. Е., Семеко, О. Р., Muscherova, D. M., Сергеевна, З. К., Миронова, В. А., Морозов, С. Л., Саркисян, М. А., & Шумилов, П. В. (2025) · Педиатрия Восточная Европа · doi:10.34883/pi.2025.13.4.006 · Cited by 1
Sun, L., Luo, Z., Zou, X., Sun, C., Peng, F., Peng, C., & Zhou, Q. (2026) · BMC Microbiology · doi:10.1186/s12866-026-04890-3 · Cited by 1
Liu, W., Zhao, M., Wang, M., Sun, S., Du, S., Wang, L., & Wang, S. (2026) · ChemistrySelect · doi:10.1002/slct.202507500 · Cited by 1
Weichert, M., Schumann, M. R., Brandt, U., Bedford, C., Brand, A., & Fleißner, A. (2026) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkag075 · Cited by 1
Yang, Z., Zhang, Y., Li, D., Wang, S., Shi, R., & Shi, D. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01645-25 · Cited by 1
Dai, T., Chen, A. X., Chow, E. W. L., Pang, L. M., Li, J. M., Verma, C. S., Oehlers, S. H., Wang, Y., & Li, N. (2026) · Advanced Science · doi:10.1002/advs.75480 · Cited by 1
Yuan, H., Yan, C., Pan, Q., Chen, K. Y., Xie, X., Zhang, J., Wen, C., Li, Y., & Zhang, L. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126973 · Cited by 1
Arteaga-Crespo, Y., Quintana, Y. G., Velásquez-López, Y., Radice, M., Conforme-García, M. M., Barreto, J. L. R., Salas, J. B., & Abreu-Naranjo, R. (2026) · Molecules · doi:10.3390/molecules31111891 · Cited by 1
New Biological Targets in Fungi and Novel Molecule under Development: A Review
Coulibaly, S., N'Guessan, J.-P. D. U., Kacou, A. A., Koffi, J.-F. K., Diakité, A. S., Kouaho, T. K. A., & Ouattara, M. (2021) · Chemical Science International Journal · doi:10.9734/csji/2021/v30i630235 · Cited by 1
Grey, A., Joubert, R., Steyn, S. F., & Julyan, M. (2023) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v38i1.470 · Cited by 1
Nesvizhsky, Y. V., Afanasiev, S. S., Voropaev, A. D., Urban, Y. N., Suleimanova, M. E., Afanasiev, M. S., Budanova, E. V., & Voropaeva, E. A. (2023) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-407 · Cited by 1
Rabbi, F., Nisar, A., Nawaz, N. U. A., AlMasoud, N., Alomar, T. S., & Rauf, A. (2023) · Micro & Nano Letters · doi:10.1049/mna2.12179 · Cited by 2
Tavakkoli, A., Asili, J., Soheili, V., Iranshahy, M., Saiar, M., Najafzadeh, M. J., & Iranshahi, M. (2023) · Journal of Essential Oil Bearing Plants · doi:10.1080/0972060x.2023.2280140 · Cited by 2
Antimicrobial and antibiofilm activities of Inga cylindrica trypsin inhibitor
Pereira, A. P. R., Jacobowski, A. C., Sardi, J. D. C. O., Almeida, C. V., Almeida, L. H. D. O., Silva, M. A. A. G., & Macedo, M. L. R. (2024) · Brazilian Journal of Biology · doi:10.1590/1519-6984.283106 · Cited by 1
Genome-Scale Metabolic Models in Fungal Pathogens: Past, Present, and Future
Fonseca-Fernández, A. L., Barrios, A. F. G., & Ramírez, A. M. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910852 · Cited by 1
Nanotherapeutics and nanotheranostics in miscellaneous fungal infections
Kaur, A., Raj, K., Rajput, P., & Bhatia, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-28836-4.00020-2 · Cited by 1
Patne, K., Rath, P. P., Khan, F. M., Ramachandran, V., Sharma, S., Arya, V., Gourinath, S., & Muthuswami, R. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147031 · Cited by 1
Emergence of Candida auris - A Human Isolate with Atorvastatin as a Growth Promoter
Attas, M. K. A., Naqvi, S., Kumar, V., Al-Abbasi, F. A., Alhayyani, S., & Anwar, F. (2022) · International Journal of Pharmacology · doi:10.3923/ijp.2022.1079.1083 · Cited by 1
Evolutionary diversity of the control of the azole response by Tra1 across yeast species
Marsiglio-Librais, G. N., Jiang, Y., Razzaq, I., Brandl, C. J., Shapiro, R. S., & Lajoie, P. (2023) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkad250 · Cited by 1
Sphingolipid Homeostasis, Mitochondrial Activity, and PKA Signaling Drive an Azole-Tolerant StatePreprint
Gautier, C., Maciel, E. I., Maufrais, C., Lyons, N., Kawar, N., Bibi, C., Eickmann, C., Rosenberg, A., Dasilva, D., De, N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.12.675915 · Cited by 1
Nunez‐Rodriguez, J. C., Biriukov, V. V., Redondo-Río, Á., Parmar, M., Schikora-Tamarit, M. À., Ahaik, I., del Olmo, V., & Gabaldón, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.19.725100 · Cited by 1
Zhao, Q., Huang, X., Liu, Q., Cao, Y., Yu, X., Liu, Y., Hu, N., Han, Z., Tan, J., Li, X., et al. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.01672-25
“As a major pathogen of invasive fungal infections (27), elucidating the virulence mechanisms of C. albicans is crucial for antifungal drug development.”
Potential role of lysine acetylation in the stepwise adaptation of Candida albicans to fluconazole
Song, N., Huang, Y., Zhou, X., Li, D., Liu, W., & Li, X. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02797-24
“In addition, large-scale genomic alterations, including aneuploidy, loss-of-heterozygosity (LOH), and chromosomal rearrangements, can affect the expression of drug targets, efflux pumps, and other resistance factors (7).”
Germination of a Field: Women in Candida albicans Research
Anderson, F. M., Polvi, E. J., Veri, A. O., & O’Meara, T. R. (2021) · Current Clinical Microbiology Reports · doi:10.1007/s40588-021-00169-5
Call for Papers: Drug Resistance in Infectious Diseases and Beyond
Schiffer, C. A., & Hazuda, D. J. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00103
Lu, Y., Yu, M., Huang, M., Liu, Y., Guo, T., & Wu, Q. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4133025
Lu, Y., Yu, M., Huang, M., Liu, Y., Guo, T., & Wu, Q. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4103417
Castillo-González, A. R., Favila-Pérez, M. A., Ishida-Gutiérrez, M. C., Quiñonez-Flores, C. M., Román-Aguirre, M., Leyva‐Porras, C., Camarillo‐Cisneros, J., & Arzate-Quintana, C. (2022) · Microscopy and Microanalysis · doi:10.1017/s1431927622005724
Perspective Chapter: Antifungal Drug Resistance in Candida Species
Turan, D. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106970
CONTRIBUIÇÕES DA IMERSÃO NO CONTEXTO DA SAÚDE COLETIVA PARA A FORMAÇÃO AMPLIADA EM SAÚDE
Laguna, G. G. D. C., Silva, A. D. A., Lima, D. B. A., Souza, P. F. D. M., Kochergin, C. N., & Bezerra, V. M. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c5
PAPILOMATOSE RESPIRATÓRIA RECORRENTE: UMA REVISÃO LITERÁRIA
Veras, A. B. D. A., SOUSA, E. A. D., Rodrigues, L. M. R., Borges, M. C. S. T., Veras, R. P. M., da Silva, T. S., Carvalho, T. D., & Medeiros, N. T. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c15
ATIVIDADE ANTIFÚNGICA DO ÓLEO ESSENCIAL DE Cinnamomum cassia FRENTE A Candida albicans
Oliveira, A. F. M., da Silva, R., Costa, S. T. D. S., Brandão, F. G. D. S., Araújo, C. S., Farias, P. M. S., Candeira, S. J. N., & dos Santos, R. R. L. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c3
DISFUNÇÃO SEXUAL PÓS PROSTATECTOMIA RADICAL: UM RELATO DE CASO
de Araújo, A. L. S. L. B. R., de Freitas, E. B., Araújo, P. C., de Lima, M. A., & Marinho, A. C. D. N. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c7
Silva, S. D. L. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c4
de França, M. S., da Silva, L. A. C., de Araújo, V. S., de Almeida, D. K. F. H., Soares, B. K. P., de Castro, K. M. S., & Magalhães, A. G. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c12
FERTILIDADE EM PACIENTES COM TRAUMA RAQUIMEDULAR PRÉVIO
Roza, L. G. E., Oliveira, I. D. F., & Lopes, C. E. Z. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c11
Soares, M. D. A. O., Nogueira, D. L., Martins, K. M. C., da Silva, M. D. C. N., Oliveira, I. D. S., de Sousa, M. V. A., & dos Santos, S. B. C. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c6
EFEITOS DA SUPLEMENTAÇÃO COM CREATINA NO CASO DE PRATICANTES DE TAEKWONDO: UMA REVISÃO SISTEMÁTICA
Rosa, L. A. S., de Sousa, L. M., da Silva, M. C. N., Vasconcelos, A. S., Câmara, J. N. R., da Cruz, T. M., & Sampaio, R. M. M. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c8
Nunes, J. M. P. F. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c9
EPIDEMIOLOGIA, DIAGNÓSTICO E INTERVENÇÃO EM SAÚDE PÚBLICA
Silva, I. N. V. D. P., Nunes, J. K. O., Filho, P. S. D. P. S., & Mota, L. P. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028
A IMPORTÂNCIA DA PARTICIPAÇÃO EM LIGAS ACADÊMICAS NO CONTEXTO DO ENSINO REMOTO EMERGENCIAL
Portela, E. K. O., da Silva, M. L., Custódio, D. D. F., Araujo, P. J. S., Teles, R. D. A., Rabelo, A. K. B., Tavares, B. M. D. B., & Fernandes, E. D. B. D. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c2
Pantoja, G. M., Marques, A. G. B., de Vasconcelos, C. E. N., de Souza, D. V. R., Silva, L. E. S. E., Guimarães, V. L., Parente, J. S., & Valois, R. C. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c10
de Araújo, A. L. S. L. B. R., de Araújo, G. Y. M. D. N. P., da Silva, M. S. H., Pena, M. P. D., Ferreira, O. G. L., & Neves, J. D. F. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c14
PESQUISA SOBRE ACESSO E ASSISTÊNCIA A SAÚDE AOS TRABALHADORES NO MUNICIPÍO DE QUIXADÁ – CEARÁ
Brandão, L. C. D. S., Lima, I. C. D. S., & da Silva, N. H. M. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c16
Kholodov, А. А., Zakharova, Y. V., Otdushkina, L. Y., Олеговна, Б. Е., & Pyanzova, T. V. (2022) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-fot-1974
Silva, M. A. K. F., Moreira, L. V., Penha, N. S. A., Brandão, R. N., Tonatto, G. C. C., Guedes, R. D. Q. F., Feijó, C. K., Ferreira, D. B. M., Martins, A. G., & Rocha, A. S. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230110c19
Assessment of Antifungal activity of Probiotics against candidiasisPreprint
Shree Abiraami, N. S., Narayan, V., & Rajesh, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2895271/v1
A Hybrid Approach for Classifying Drug-Resistant Microscopic Species
Harshitha, D. G., & Jamadagni, S. (2023) · International Conference on Networks, Multimedia and Information Technology (NMITCON) · doi:10.1109/nmitcon58196.2023.10276032
Villagómez‐Guzmán, A. K., García‐Bores, A. M., López-Pérez, M. A., Estrella-Parra, E. A., Ávila-Acevedo, J. G., Gómez‐Cansino, R., Bustamante-Camilo, P., & Hernández, T. (2023) · Research Square · doi:10.21203/rs.3.rs-3617577/v1
Yang, H. J., Ma, Y., Li, B., Xi, Z., Zhang, L., Wang, Y., & Feng, W. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s431024
Spindle checkpoint activation by fungal orthologs of the S. cerevisiae Mps1 kinase
Fabritius, A. S., Alonso, A., Wood, A., Sulthana, S., & Winey, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301084
Adherence of Candida albicans to fibrin-clot matrices in a rat model for type 2 diabetes
Plotkin, B. J., & Konaklieva, M. I. (2024) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2024.18.2.0257
Li, S., Liu, J., Zhang, T., Lu, J., Li, M., Zhang, M., & Chen, H. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13633
Antifungal Resistance in Candida Species: A Bit from the Totality
AL‐Janabi, A. A. H. S. (2024) · Anti-Infective Agents · doi:10.2174/0122113525309478240528081719
Barzegari, A. A., Zare, M., Parvizpour, S., & Razmara, J. (2024) · Armaghane Danesh · doi:10.61186/armaghanj.29.4.610
Introductory Chapter: Candidiasis and Antifungal Drug Resistance Feature
Behzadi, P. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005643
Bhat, S., Nagaraj, A., Poojar, B., & Narasimhaswamy, N. (2024) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000394
MDR in Candida: The Real Storm
Srivastava, P., Tiwari, S., Kumar, M., Murhekar, M. V., & Dwivedi, G. R. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_4
Description of environmental stress mediators in Candida species
Enoktaeva, O. V. (2024) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-doe-17691
Neonatal Immunity to Candida: Current Understanding and Contributions of Murine Models
Palacios, Á., Kumar, A., Caliwag, F. M. C., & Becerril-García, M. A. (2024) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2024055053
Effectiveness of drug repurposing approach against Candida isolates
Ansari, A., Saini, M. K., Kumar, D., Rai, N., & Kumar, N. (2024) · Environment Conservation Journal · doi:10.36953/ecj.30540224
A incidência de Candida albicans no exame de urina de homens e mulheres
Tenório, K. D. S., de Castro, L. S., Machado, H., de Abreu, R. R., de Lima, F. K. R., Ferreira, A. V. D., Barros, N. B. D., & Carvalho, J. F. C. D. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n9-460
Bohner, F. (2024) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12031
Antifungal resistance of dermatophytes and pitfalls in treatment of superficial mycoses
Sergeev, A. Y. (2024) · Immunopathology Allergology Infectology · doi:10.14427/jipai.2024.3.47 · Cited by 1
Wilson, L., Nielsen, K., Villanueva, S. C., O'Brien, T., Hefner, L. A., Slick, P., Petty, L., Dienna, R., Castillo, H. A., & Chavez, A. A. (2025) · Life Sciences in Space Research · doi:10.1016/j.lssr.2025.01.002
Choi, J.-J., Kang, S. H., Lee, Y., Lee, D.-H., Jang, Y., Goo, J.-I., Choi, Y., Lee, D., & Yun, C. (2025) · Bioscience Reports · doi:10.1042/bsr20250001
Self-citationEditorial: Methods in experimental pharmacology 2023
Arumugam, S., Khurana, A., & Bharani, K. K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1531464
Sah, S. K., Yadav, A., Stahl, T. J., Hayes, J. J., Bulger, M., & Rustchenko, E. P. (2025) · Journal of Fungi · doi:10.3390/jof11020110
Leite, S. H. D. A., Silva, D. R., Vasconcelos, P. G. S., Silva, J. P. R. E., & Catão, M. H. C. D. V. (2025) · Caderno Pedagógico · doi:10.54033/cadpedv22n4-052
Antifungal Agents and Therapeutic Approaches in the Treatment of Invasive Fungal Infections
Choudhary, P., Punia, A., Kumari, S., & Chhillar, A. K. (2025) · Current Bioactive Compounds · doi:10.2174/0115734072368372250203055808
Bioactive Molecules of Microbial Origin
Ganguly, D., Sengupta, S., Ghosh, S., Sengupta, S., & Goswami, G. (2025) · Sustainable landscape planning and natural resources management · doi:10.1007/978-3-031-76859-0_2
Jihad, M. F., & Salih, M. B. (2025) · Ukrainian Journal of Nephrology and Dialysis · doi:10.31450/ukrjnd.1(85).2025.05
A review of human pathogenic fungi prevalence, resistance and detection methods
Li, K. (2025) · Highlights in Science Engineering and Technology · doi:10.54097/mv92f297
Khoury, P. E., Zeidan, A., & Khalaf, R. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320484
Zheng, F., Ge, X., Guan, Y., Zhou, Q., Shi, R., Zhao, J., Situ, B., Zhang, J., & Rui, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1566846
Akbar, Z., Aamir, M., Saleem, Z., Niazi, M. R. K., Ejaz, H., Alruwaili, M., & Abosalif, K. O. A. (2025) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.70022
Promising Role of Fruitless Wolfberry Bud Tea in Combating Nakaseomyces glabratus Resistance
Zhang, L., Ma, Z., Zhou, X., Zhang, Z., & Wu, T. (2025) · Pathogens · doi:10.3390/pathogens14040351
A Range of Biological Medications Utilized for The Treatment of Fungal Infections
Kumar, R., Singh, A., Garg, S., Kaur, R., & Koundal, R. (2025) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2025.v07i03.43715
Pinosylvin and Sanguinarine Combination to Enhance Antifungal Activity against Candida albicans
Yue, Y., Liu, J., Li, C., Chen, F., Yang, C., & Zhao, B. T. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2412.12055
Бліндер, O. O., Blinder, O. V., Humenna, A. V., Deineka, S. Y., & Mikheev, A. (2025) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2025.2.318170
Putri, N. D., & Prayekti, E. (2025) · Journal of Indonesian Medical Laboratory and Science (JoIMedLabS) · doi:10.53699/joimedlabs.v6i1.223
A Metalless and Fungicide-Free Material Against Candida: Glass-Loaded Hydrogels
Peiter, G. C., Salvador, E. D. S., Ayma, F. C., Teixeira, K. N., Jaerger, S., Bini, R. A., Busso, C., de Oliveira, R. J., & Schneider, R. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070836
Venchakova, V. V., Oganesyan, E. G., Guseva, A. O., Kovyrshin, S., Rusetskaya, E. V., Marochkovich, O. A., Dolgo-Saburova, Y. V., Богомолова, Т. С., Zhang, F.-M., Meng, Q., et al. (2025) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2025.1.73-87
Nesvizhsky, Y. V., Afanasiev, S. S., Зверев, В. В., Voropaev, A. D., Afanasiev, M. S., Александровна, В. Е., Budanova, E. V., Smirnova, L. M., Anisova, S. A., & Urban, Y. N. (2025) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-653
Lim, S. J., Noor, N. D. M., Sabri, S., Ali, M. S. M., Kumari, P., Kumari, S., Gaur, N. A., Salleh, A. B., & Oslan, S. N. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107937
Synthesis and Antifungal Evaluation Against Candida spp. of 5-Arylfuran-2-Carboxamide Derivatives
Mirabile, S., Ginestra, G., Pennisi, R., Barreca, D., Mandalari, G., & Gitto, R. (2025) · Microorganisms · doi:10.3390/microorganisms13081835
Pancatalytic biomaterials enable inflammation-related disease intervention
Jiang, X., & Chen, Y. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00408j
Enongene, R. B., Toh-Boyo, G. M., Ndosiri, B. N., Nfor, E. N., Ofiong, O. E., & Louis, H. (2025) · Computational Chemistry · doi:10.4236/cc.2025.134004
Hussein, B., & Abuod, M. S. (2025) · Journal of education for pure science. · doi:10.32792/jeps.v15i3.663
Resistome and Resistance Mechanisms of Candidozyma Auris Clade IV: A Systematic Review
Bonilla-Caballero, M. A., Álvarez, G., & González, Á. F. (2025) · Current Tropical Medicine Reports · doi:10.1007/s40475-025-00353-3
Cabrera, A., Trigos, Á., Ramos, A., Serrano-Márquez, L., & Mendoza, G. (2025) · International Journal of Agronomy · doi:10.1155/ioa/6121036
Understanding Fungi-Host Dynamics: The Role of Immuno Suppression and Real-World Clinical Scenario
Mazhar, S. S., Panche, A. N., Mohiuddin, I. M., Deshmukh, R., & Harke, S. N. (2025) · Current Fungal Infection Reports · doi:10.1007/s12281-025-00514-x
Combined Approaches for Photodynamic Inactivation Against Oral Biofilms
Pavarina, A. C., Dovigo, L. N., Dias, L. M., & Jordão, C. C. (2025) · Springer eBooks · doi:10.1007/978-3-031-55858-0_77-1
Metadata
- Authors
- Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Cowen, Leah E.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-05-22
- Volume
- 121
- Issue
- 6
- Pages
- 3390-3411
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- PMC
- PMC8519031
- OpenAlex
- W3026958586
- Cited by
- 801
- References
- 237
- Citations by year
- 2026: 109 · 2025: 192 · 2024: 168 · 2023: 133 · 2022: 132 · 2021: 63 · 2020: 4
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Canadian Institutes of Health Research (FDN-154288)
- National Institute of Allergy and Infectious Diseases (1R01AI127375-01)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- antifungal resistance, Candida albicans, Candida auris, Candida glabrata, invasive candidiasis, antifungal agents, molecular mechanisms of resistance, combination antifungal therapy, fungal virulence factors, emerging fungal pathogens
- MeSH terms
- Drug Development, Animals, Antifungal Agents, Candida, Candida albicans, Drug Therapy, Combination, Humans, Mycoses, Virulence, Molecular Structure, Signal Transduction, Drug Resistance, Fungal, Candida glabrata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
